메뉴 건너뛰기




Volumn 69, Issue 10, 2006, Pages 899-905

Valdecoxib exposures reported to Texas poison centers during 2002-2004

Author keywords

[No Author keywords available]

Indexed keywords

VALDECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ISOXAZOLE DERIVATIVE; SULFONAMIDE;

EID: 33745363896     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390500360018     Document Type: Article
Times cited : (4)

References (5)
  • 1
    • 0037441311 scopus 로고    scopus 로고
    • Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor
    • Alsalameh, S., Burian, M., Mahr, G., Woodcock, B. G., and Geisslinger, G. 2003. Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor. Aliment. Pharmacol. Ther. 17:489-501.
    • (2003) Aliment. Pharmacol. Ther. , vol.17 , pp. 489-501
    • Alsalameh, S.1    Burian, M.2    Mahr, G.3    Woodcock, B.G.4    Geisslinger, G.5
  • 2
    • 85009032678 scopus 로고    scopus 로고
    • New warnings for Bextra
    • Anonymous. 2003. New warnings for Bextra. FDA Consum. 37:5.
    • (2003) FDA Consum. , vol.37 , pp. 5
  • 3
    • 3042780220 scopus 로고    scopus 로고
    • Valdecoxib: A review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain
    • Fenton, C., Keating, G. M., and Wagstaff, A. J. 2004. Valdecoxib: A review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain. Drugs 64:1231-1261.
    • (2004) Drugs , vol.64 , pp. 1231-1261
    • Fenton, C.1    Keating, G.M.2    Wagstaff, A.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.